BML, Inc. (4694.T)

JPY 2853.0

(1.89%)

Operating Income Summary of BML, Inc.

  • BML, Inc.'s latest annual operating income in 2023 was 9.16 Billion JPY , down -61.7% from previous year.
  • BML, Inc.'s latest quarterly operating income in 2024 Q1 was 2.54 Billion JPY , up 78.18% from previous quarter.
  • BML, Inc. reported an annual operating income of 23.93 Billion JPY in 2022, down -51.04% from previous year.
  • BML, Inc. reported an annual operating income of 48.88 Billion JPY in 2021, up 145.23% from previous year.
  • BML, Inc. reported a quarterly operating income of 2.61 Billion JPY for 2023 Q3, up 6.43% from previous quarter.
  • BML, Inc. reported a quarterly operating income of 1.43 Billion JPY for 2023 Q4, down -45.29% from previous quarter.

Annual Operating Income Chart of BML, Inc. (2023 - 2004)

Historical Annual Operating Income of BML, Inc. (2023 - 2004)

Year Operating Income Operating Income Growth
2023 9.16 Billion JPY -61.7%
2022 23.93 Billion JPY -51.04%
2021 48.88 Billion JPY 145.23%
2020 19.93 Billion JPY 104.2%
2019 9.76 Billion JPY -6.57%
2018 10.45 Billion JPY 11.92%
2017 9.33 Billion JPY 0.09%
2016 9.32 Billion JPY 10.68%
2015 8.42 Billion JPY 20.86%
2014 6.97 Billion JPY -14.83%
2013 8.18 Billion JPY 23.37%
2012 6.63 Billion JPY 25.23%
2011 5.3 Billion JPY -19.96%
2010 6.62 Billion JPY 1.89%
2009 6.49 Billion JPY 16.2%
2008 5.59 Billion JPY 15.52%
2007 4.84 Billion JPY 60.18%
2006 3.02 Billion JPY -39.77%
2005 5.01 Billion JPY 16.85%
2004 4.29 Billion JPY 0.0%

Peer Operating Income Comparison of BML, Inc.

Name Operating Income Operating Income Difference
Shin Nippon Biomedical Laboratories, Ltd. 4.16 Billion JPY -120.26%
DNA Chip Research Inc. -258.21 Million JPY 3650.516%
Cosmo Bio Company,Limited 519 Million JPY -1666.474%
H.U. Group Holdings, Inc. -4.04 Billion JPY 326.762%
FALCO HOLDINGS Co., Ltd. 2.15 Billion JPY -326.022%
Human Metabolome Technologies, Inc. 220.16 Million JPY -4064.093%
Precision System Science Co., Ltd. -956.24 Million JPY 1058.749%